B Com (Hons), CA (SA), CMS (Oxon)
Member of the remuneration and nominations committee
Appointed to the board in 2013
John spent over three decades in commerce and industry, including serving as a partner of Ernst & Young and holding a number of financial directorships. He is a non-executive director of Clicks Group, HomeChoice, Personal Trust International and Tower Property Fund.
BA, LLB, LLM
Chairman of the audit and risk committee
Appointed to the board in 2013
Bharti spent 14 years at the Industrial Development Corporation of South Africa where she headed the corporate funding and international finance departments. She is a director of Bell Equipment Sales South Africa Limited, the Mineworkers Investment Company, Stefanutti Stocks and Lenmed Investments.
B Com (Hons), CA (SA), MBA
Member of the audit and risk, and social and ethics committees
Appointed to the board in 2016
Mary is the CEO of the Mineworkers Investment Company and has held senior executive positions across the resources, media, utilities and financial services sectors. Her directorships include FirstRand Group, Primedia, Metrofile Holdings, and Peermont Global Holdings.
BDS (Wits), MBA
Chairman of the remuneration and nominations committee and the social and ethics committee
Member of the audit and risk committee
Appointed to the board in 2016
Kinesh is the chairman of Kilimanjaro Capital and a director of Kefolile Health Investments and Bataung Energy Holdings. He has extensive experience in the trade union investment arena and has been instrumental in several significant BEE transactions in the healthcare and pharmaceutical sectors.
B Com, CA (Zim)
Appointed to the board in 2008
Gary is the majority beneficial owner and CEO of Coast2Coast Capital which founded Ascendis Health in 2008 and listed it on the JSE in November 2013. As CEO of Coast2Coast Capital, Gary has been involved in all phases of the firm’s development since its founding in late 2007 and is responsible for the overall strategy and management of the company. Apart from Ascendis, Gary co-founded Bounty Brands (Pty) Ltd in 2014 and Marlin Brands (Pty) Ltd in 2016, a group of companies that employ in excess of 10 000 staff in Europe, South Africa and Australia. Gary also serves on the board of a number of portfolio companies.
BA (Marketing Management), BA (Anthropology), MBA executive programmes (London, INSEAD, IMD)
Appointed to the board in March 2018
Thomas joined the group in 2017 as head of the European operations, based in London, and was appointed as CEO in March 2018. He has held senior executive positions at Johnson & Johnson Consumer (MD CEE region), Reckitt Benckiser (head of global consumer healthcare) and Novartis Consumer Healthcare (head of global consumer health category). Most recently he has focused on non-executive board positions for private equity and listed companies mainly in the pharma sector.
B Com (Hons), H Dip (Auditing), CA (SA)
Appointed to the board in 2015
Kieron has over 20 years experience in financial management across a range of industries, including five years at GlaxoSmithKline Consumer Health care in the UK and Dubai, five years as CFO at TransUnion Group Africa and two years as CEO of Nando’s Company-owned Restaurants Division.
MB BCh (Wits), MBA
Appointed to the board in June 2018
Dr Jekwa has 13 years’ experience in the financial services industry where she has held senior positions at Rand Merchant Bank and Nedbank Capital. Before entering structured financing, Dr Jekwa worked in the medical field in South Africa and in the UK. She is a director of Coast2Coast Capital and Northam Platinum.
